Skip to main content

Select Drug Profiles

Pembrolizumab Doubles Progression-Free Survival in Subset of Patients with Metastatic Colorectal Cancer
Wayne Kuznar
Chase Doyle
Read More
Multiple Myeloma, Oncology
CAR T-Cell Therapy Shows Deep, Durable Responses in Relapsed or Refractory Multiple Myeloma
Chase Doyle
Chase Doyle
Read More
Breast Cancer, Oncology
Pembrolizumab Added to First-Line Chemotherapy Improves Progression-Free Survival in Metastatic TNBC
Chase Doyle
Wayne Kuznar
Read More
Breast Cancer, Oncology
No Survival Benefit with Surgery and Radiation Added to Systemic Therapy in Patients with Newly Diagnosed Stage IV Breast Cancer
Phoebe Starr
Phoebe Starr
Read More
Prostate Cancer
Cabozantinib plus Atezolizumab Combination Shows Meaningful Activity in Metastatic Prostate Cancer
Phoebe Starr
Phoebe Starr
Read More
FDA Approvals
FDA News: August 2020
Read More
Ovarian Cancer
Olaparib Extends Survival by >1 Year in Patients with Ovarian Cancer and BRCA Mutation, Ushering in Personalized Medicine in This Malignancy
Wayne Kuznar
Wayne Kuznar
Read More
Practice Management
ASCO 2020 Presidential Address: Accelerating Progress, Prioritizing Diversity
Wayne Kuznar
Wayne Kuznar
Read More
Prostate Cancer
Oral Relugolix Equals Standard ADT, Slashes Cardiac Events in Patients with Advanced Prostate Cancer
Phoebe Starr
Phoebe Starr
Read More
Lung Cancer, Oncology
Adjuvant Osimertinib a Practice-­Changing Treatment in Early-Stage NSCLC with EGFR Mutation
Wayne Kuznar
Wayne Kuznar
Read More
Page 32 of 244
Results 311 - 320 of 2438